Latest Capital Securities News

HMC Capital has cleared key regulatory hurdles and locked in a $603 million investment from KKR, trimming its stake in the energy platform now rebranded as Illuma Energy. The deal paves the way for expanded battery storage projects and underpins a targeted development milestone in 2026.

FOS Capital's Aldridge Traffic Systems subsidiary has landed a $0.5 million contract to supply advanced ITS lighting for the NELP Eastern Freeway Upgrade, marking its largest order since acquisition and boosting the group’s order book to $9 million.

FOS Capital, through its Aldridge Traffic Systems arm, has landed its largest contract to date, supplying advanced ITS lighting for a major Victorian freeway upgrade, lifting its order book to $9 million.

Sandon Capital has completed a $9 million conditional placement of notes, pending approval of a key Restructure Proposal by noteholders in June. The raise aims to support potential redemptions, working capital, and new investments.

Maronan Metals has completed a major share distribution from Red Metal, expanding its shareholder base, while locking in a $22 million strategic investment to fund an ambitious drilling program and feasibility study.

Emmerson Resources Limited shareholders will vote on a Court-approved scheme to be acquired by Pan African Resources, exchanging shares for Pan African CDIs and gaining exposure to a larger gold producer.

Sandon Capital Investments has locked in $2.67 million through an institutional placement priced in line with its recent share purchase plan and dividend reinvestment plan.

Patronus Resources has pledged to back Pan African Resources’ A$311 million acquisition of Emmerson Resources, raising committed shareholder support to about 32%. The backing is conditional on the share exchange ratio, absence of superior proposals, and a positive independent expert opinion.

Neurizon Therapeutics has secured an additional A$2.7 million through a placement addressing the shortfall from its entitlement offer, lifting total proceeds to approximately A$8.5 million. This fresh capital strengthens the biotech’s balance sheet and provides financial flexibility as it advances its lead ALS drug NUZ-001 through pivotal clinical stages.

Temas Resources is tapping the Canadian market with a $1.5 million flow-through share placement aimed at advancing its titanium projects in Quebec. The raise supports exploration expenses tied to its proprietary processing technology and resource development.

ActivEX Limited has completed a $393,505 share placement, issuing nearly 20 million shares at 2 cents each, with funds earmarked for advancing exploration projects and supporting working capital.

Chimeric Therapeutics has secured a $1.785 million advance against its anticipated FY26 Research and Development Tax Incentive to bolster its clinical trial pipeline and working capital.